AEON Biopharma Stock Quote AEON - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.76

Bid

Ask

Volume

52,404

0.74 Day's Range 0.8121

0.7066 52 Week Range 17.17

Market Cap

30.037M

Previous Close

0.769

Open

0.8121

Last Trade

257

0.76

Last Trade Time

Financial Volume

$ 40,269

VWAP

0.768436

Average Volume (3m)

1,888,501

Shares Outstanding

39,522,238

Dividend Yield

PE Ratio

1.25

Earnings Per Share (EPS)

0.61

Revenue

52.75M

Net Profit

24.05M

AEON Biopharma, Inc. is a bio-pharmaceutical company. The Company is focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions with an initial focus on the neurology and gastroenterology markets. ABP-450 contains a 900 kDa botulinum toxin type-... AEON Biopharma, Inc. is a bio-pharmaceutical company. The Company is focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions with an initial focus on the neurology and gastroenterology markets. ABP-450 contains a 900 kDa botulinum toxin type-A complex produced by the bacterium clostridium botulinum. The active part of the botulinum toxin is the 150 kDa component, and the remaining 750 kDa of the complex is made up of accessory proteins. When injected at therapeutic levels, ABP-450 blocks peripheral acetylcholine release at presynaptic cholinergic nerve terminals by cleaving SNAP-25, a protein integral to the docking and release of acetylcholine from vesicles situated within the nerve endings leading to denervation and relaxation of the muscle. It is also engaged in the Phase II clinical study of ABP-450 for the treatment of cervical dystonia. Cervical dystonia, also known as spasmodic torticollis, is a neurological condition. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Headquarters

Wilmington, Delaware, USA

Founded

2022

AEON Biopharma Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker AEON. The last closing price for AEON Biopharma was $0.77. Over the last year, AEON Biopharma shares have traded in a share price range of $ 0.7066 to $ 17.17.

AEON Biopharma currently has 39,522,238 shares outstanding. The market capitalization of AEON Biopharma is $30.39 million. AEON Biopharma has a price to earnings ratio (PE ratio) of 1.25.

FeaturedElement79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.04	-5	0.8	0.86	0.7066	90493	0.8150153	CS
4	-0.29	-27.619047619	1.05	1.1	0.7066	93311	0.91990207	CS
12	-0.65	-46.0992907801	1.41	3.74	0.7066	1888501	2.43638982	CS
26	-10.72	-93.3797909408	11.48	17.17	0.7066	915573	2.63370966	CS
52	-4.17	-84.584178499	4.93	17.17	0.7066	470479	2.76348951	CS
156	-9.38	-92.5049309665	10.14	17.17	0.7066	434423	2.9307577	CS
260	-9.38	-92.5049309665	10.14	17.17	0.7066	434423	2.9307577	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BURUNuburu Inc	$ 0.67 (29.59%)	12.89M
VINEFresh Vine Wine Inc	$ 0.4988 (23.16%)	473.69k
MSOXAdvisorshares Msos 2x Daily ETF	$ 2.33 (22.63%)	5.09M
RYDERyde Group Ltd	$ 20.24 (16.79%)	5.64M
BTCLT Rex 2X Long Bitcoin Daily Target ETF	$ 21.76 (14.29%)	204.75k
VHAIVocodia Holdings Corp	$ 0.0318 (-18.46%)	52.93M
SBITProshares Ultrashort Bitcoin ETF	$ 40.06 (-13.59%)	782.29k
BTCZT Rex 2X Inverse Bitcoin Daily Target ETF	$ 20.83 (-12.84%)	24.64k
UVIX2x Long VIX Futures ETF	$ 5.37 (-12.68%)	24.83M
ETHDProshares Ultrashort Ether ETF	$ 72.61 (-11.38%)	16.99k
SOXLDirexion Daily Semiconductor Bull 3X Shares	$ 27.43 (5.66%)	84.47M
SOXSDirexion Daily Semiconductor Bear 3X Shares New	$ 28.97 (-6.03%)	55.23M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	$ 7.80 (-3.23%)	53.01M
VHAIVocodia Holdings Corp	$ 0.0318 (-18.46%)	52.93M
SHProShares Short S&P500 New	$ 11.52 (-1.12%)	40.66M